Mechanism of Action of Aromatase Inhibitors and Tamoxifen. In contrast, aromatase inhibitors markedly suppress plasma estrogen levels in postmenopausal women by inhibiting or inactivating ...

For patients receiving up-front treatment with tamoxifen, the extension of tamoxifen 2,3 or an aromatase inhibitor to 10 years has been shown to be beneficial in reducing the ongoing risk of ...

Aromatase inhibitors cause unwanted side effects. More and more women are choosing not to take them, but is this a good idea? The decision to walk away from taking aromatase inhibitors is a choice ...

While aromatase inhibitors usually don’t take the place of those treatments, they can offer extra help if you’re in a select group. They’re a hormone therapy used to treat some ovarian ...

Many people who’ve had breast cancer take medications – tamoxifen or aromatase inhibitors – to help prevent the cancer from coming back. Doctors prescribe them for people with “hormone ...

Treatment with an aromatase inhibitor, either alone or in combination with growth hormone (GH), slowed bone advancement and enhanced adult height in mid-pubertal boys with a short predicted adult ...

DEAR DR. ROACH: I am an 80-year-old female and a 25-year survivor of ovarian cancer. In the past three years, I have also had Merkel cell cancer, breast cancer, and now squamous cell cancer on my lip.

I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want to ...

Researchers found that 44.8% of the 357 patients exhibited coronary artery calcium; groups had no significant difference in aromatase inhibitor treatment duration. HealthDay News — For ...

What would you recommend? -- B.C.N. ANSWER: Anastrozole is in the class of medicines called aromatase inhibitors (AIs), which block the body from making estrogen. AIs reduce estrogen levels by ...

Aromatase inhibitors act through pure oestrogen deprivation to achieve an endocrine response in oestrogen receptor (ER)-positive breast cancer. Both experimental and clinical data now confirm that ...